341 related articles for article (PubMed ID: 36126038)
1. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
Wu H; Xue M; Wu C; Lu Q; Ding Z; Wang X; Fu T; Yang K; Lin J
PLoS One; 2022; 17(9):e0274421. PubMed ID: 36126038
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012.
Gui J; Liu Z; Zhang T; Hua Q; Jiang Z; Chen B; Gu H; Lv H; Dong C
PLoS One; 2015; 10(9):e0139109. PubMed ID: 26422015
[TBL] [Abstract][Full Text] [Related]
3. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
5. Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance Study.
Head JR; Collender PA; Lewnard JA; Skaff NK; Li L; Cheng Q; Baker JM; Li C; Chen D; Ohringer A; Liang S; Yang C; Hubbard A; Lopman B; Remais JV
Clin Infect Dis; 2020 Dec; 71(12):3088-3095. PubMed ID: 31879754
[TBL] [Abstract][Full Text] [Related]
6. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
7. The impact of enterovirus A71 vaccination program on hand, foot, and mouth disease in Guangdong, China: A longitudinal surveillance study.
Xiao J; Zhu Q; Yang F; Zeng S; Zhu Z; Gong D; Li Y; Zhang L; Li B; Zeng W; Li X; Rong Z; Hu J; He G; Sun J; Lu J; Liu T; Ma W; Sun L
J Infect; 2022 Oct; 85(4):428-435. PubMed ID: 35768049
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological characteristics and trends of hand-foot-mouth disease in Shanghai, China from 2011 to 2021.
Wang J; Zhang S
Front Public Health; 2023; 11():1162209. PubMed ID: 37325298
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological characteristics of hand, foot, and mouth disease in Yunnan Province, China, 2008-2019.
Jiang L; Jiang H; Tian X; Xia X; Huang T
BMC Infect Dis; 2021 Aug; 21(1):751. PubMed ID: 34348655
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological Characteristics of Hand, Foot, and Mouth Disease and the Effect of EV71 Vaccination in Chengdu from 2012 to 2020].
Tang XQ; Zhang LZ; Meng JT; Chen H; Cheng Y; Yuan P; Long L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 53(6):1074-1080. PubMed ID: 36443055
[TBL] [Abstract][Full Text] [Related]
12. Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis.
Du Z; Huang Y; Bloom MS; Zhang Z; Yang Z; Lu J; Xu J; Hao Y
Hum Vaccin Immunother; 2021 Jan; 17(1):217-223. PubMed ID: 32530733
[No Abstract] [Full Text] [Related]
13. Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013-2022.
Yang Q; Liu F; Chang L; Lai S; Teng J; Duan J; Jian H; Liu T; Che G
Virol J; 2023 Sep; 20(1):202. PubMed ID: 37661256
[TBL] [Abstract][Full Text] [Related]
14. Effect of enterovirus 71 vaccination on the epidemiological characteristics and etiology in hospitalized children with hand-foot-and-mouth disease: A retrospective study from a tertiary children's hospital.
Sun J; Li Y; Yang Z; Fang Q; Chen B
Medicine (Baltimore); 2022 Sep; 101(37):e30356. PubMed ID: 36123878
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
[TBL] [Abstract][Full Text] [Related]
16. [Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017].
Zhang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):147-154. PubMed ID: 30744263
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
Liu D; Leung K; Jit M; Yu H; Yang J; Liao Q; Liu F; Zheng Y; Wu JT
Clin Microbiol Infect; 2020 Mar; 26(3):373-380. PubMed ID: 31279839
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the reproduction number and identification of periodicity for HFMD infections in northwest China.
Xia F; Deng F; Tian H; He W; Xiao Y; Sun X
J Theor Biol; 2020 Jan; 484():110027. PubMed ID: 31568791
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological and etiological characteristics of hand, foot and mouth disease among children aged 5 years and younger in Ningbo (2016 to 2019)].
Liu LL; Liu ZK; Zhang L; Li N; Fang T; Zhang DL; Xu GZ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):491-497. PubMed ID: 34145850
[TBL] [Abstract][Full Text] [Related]
20. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
Wu JT; Jit M; Zheng Y; Leung K; Xing W; Yang J; Liao Q; Cowling BJ; Yang B; Lau EH; Takahashi S; Farrar JJ; Grenfell BT; Leung GM; Yu H
PLoS Med; 2016 Mar; 13(3):e1001975. PubMed ID: 26978565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
